{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-007221","form_type":"8-K","ticker":"PROF","cik":"0001628808","company_name":"Profound Medical Corp.","filed_at":"2025-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.980165+00:00","generated_at":"2026-05-16T21:13:56.070442+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Profound Medical signs exclusive Saudi distribution deal for TULSA-PRO and Sonalleve with Al Faisaliah Medical Systems","bullets":["Exclusive distribution and supply agreement for TULSA-PRO and Sonalleve in Saudi Arabia with Al Faisaliah Medical Systems Co.","All regulatory approvals to import and sell the technologies in Saudi Arabia are already in place.","Saudi Arabia is the largest healthcare market in the Middle East; deal expands Profound's presence.","CEO Arun Menawat says FMS has a proven track record in introducing advanced medical technologies in the Kingdom."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-007221","json":"https://secwatch.observer/filing/0001171843-25-007221.json","markdown":"https://secwatch.observer/filing/0001171843-25-007221.md","text":"https://secwatch.observer/filing/0001171843-25-007221.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628808/000117184325007221/0001171843-25-007221-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628808/000117184325007221/f8k_111125.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T21:13:56.070442+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}